Changes in plasma lipids and abnormal lipoproteins in a patient with ticlopidine hydrochloride-induced hepatitis were studied. Total cholesterol, free cholesterol and phospholipids increased markedly during cholestasis. Lipoprotein electrophoresis showed a large lipoprotein-X band and a relatively small alphalipoprotein band. As cholestatic hepatitis improved, all plasma lipids were progressively decreased. A broad band of abnormal alpha-lipoprotein appeared for the first time with the decrease in the lipoprotein-X band. Both abnormal lipoproteins decreased further and eventually disappeared. The appearance of abnormal alpha lipoprotein was accompanied by changes in apoproteins. These findings suggest that abnormal alpha-lipopro might be an intermediate metabolite of lipoprotein-X.
It has been reported that cholestatic patients have various abnormal lipoproteins, including lipoprotein-X (LP-X) (1 , 2), lipoprotein-Y (3) and abnormal high density lipoproteins (4, 5). The physicochemical characteristics of these lipoproteins have been studied extensively (1-8), but their metabolic changes remain to be fully clarified. Therefore, we studied changes in plasma lipids and apoproteins in a patient with drug-induced cholestatic hepatitis, who showed remarkable increases in plasma free cholesterol and phospholipids. We found LP-X and abnormal alpha-lipoprotein in plasma during different clinical phases.
MATERIALS AND METHODS
A 65-year-old, previously normolipidemic woman visited a doctor for a general examination on September 2, 1989, and was found to be hypertensive and diabetic. Ticlopidine hydrochloride and nifedipine were prescribed. She stopped taking these drugs after fourteen days because of abdominal discomfort and skin eruption, which were suspected to be caused by drug allergy. Blood tests at the time showed no abnormality. On September 30, 1989 she was found to be icteric and was admitted to a hospital.
Some of the laboratory values were found to be abnormal: GOT 257 IU/1, GPT Each number with an arrow (1-6) in (B) indicates the day on which the lipoprotein electrophoresis pattern (shown in Fig. 2 At 140 days after jaundice was observed, all levels of plasma lipids were still above normal.
Changes in plasma apoproteins Changes in plasma apoproteins A-I, B, C-II, C-III and E are shown in Fig. 1C With the progress of cholestasis and the increase in cholesterol (Fig. 1B-1 ), an abnormal lipoprotein band (LP-X) was recognized between the origin and the beta-lipoprotein band ( Fig. 2-1) . A relatively small alpha-lipoprotein band was also recognized. With the improvement of cholestatic hepatitis and the beginning of the decrease in total and free cholesterol ( Fig. 1B-2 ), LP-X decreased and an abnormal, broad alpha-lipoprotein band with slow 19, 1990 . An aliquot of plasma was applied to an agarose plate (Helena Titan Gel Lipo) and electrophoresed for 25 min at 90 V. The plate was stained with Fat Red, dried and scanned by densitometer (Helena EDC). Abnormal lipoprotein bands were recognized: LP-X was located on the cathode side between the origin and the betalipoprotein band in (1), (2), (3) and (4). The abnormal alphalipoprotein band was located on the anode side with a broad band between the pre-beta lipoprotein band and the alphalipoprotein band in (2), (3) and (4). alpha migration was newly detected between the prebeta lipoprotein band and the alpha lipoprotein band ( Fig. 2-2) . When phospholipids began to decrease following the decline in total and free cholesterol (Fig.  1B-3) , LP-X decreased further and the abnormal alpha-lipoprotein band decreased to the extent that it could be differentiated from the normal alpha-lipoprotein band ( Fig.  2-3) .
As the values for all lipids decreased further (Fig. 1B-4) , LP-X and abnormal alpha-lipoprotein showed a remarkable decrease (Fig. 2-4) . Two weeks later (Fig.  1B-5) , both of these abnormal lipoproteins were unrecognizable on electrophoresis (Fig. 2-5) . By 140 days after the observation of jaundice (Fig. 1B-6 ), a normal lipoprotein pattern was obtained (Fig. 2-6 The origin and degradation of abnormal HDL1-C a re not well clarified.
Another abnormal HDL has been reported by Patsch et al (10) . In an in vitro experiment, they observed the appearance of abnormal HDL after the incubation of LP-X with normal plasma, and termed i t an HDL2-like particle.
It is interesting that there are clear similarities in the composition of LP-X and abnormal HDL1-C.
In addition, another abnormal HDL (HDL2-like particle)
was detected by LP-X degradation in vitro.
It could be suggested, therefore, that there might be a close relationship between LP-X and abnormal HDL in cholestasis.
To study this possibility and attempt to elucidate the origin and degradation of abnormal HDL, the following studies were carried out in a patient with drug-induced cholestatic hepatitis.
The appearance of LP-X with cholestasis is wellknown, as mentioned above, but the clinical changes in this abnormal lipoprotein have not been well elucidated. The case presented here made it easy to follow the clinical changes in abnormal lipoproteins, because a large amount of abnormal lipoprotein was obtained and cholestasis was improved after withdrawal of the causative drugs. We have also observed the appearance of abnormal lipoproteins in cases with obstructive jaundice due to bile duct carcinoma (data not shown). In contrast to the former case, however, abnormal lipoproteins and cholestasis in the latter cases persisted till their death. Therefore, the case presented here could be considered a good model to investigate the metabolic changes in abnormal lipoproteins compared to cases with obstructive jaundice.
The electrophoretic patterns of lipoprotein showed the appearance of LP-X with cholestasis in the early phase. report and the present patient indicate that LP-X appears at least in some severe cholestasis induced by ticlopidine hydrochloride.
